Cargando…
The Current State of Neoadjuvant Therapy in Resectable Advanced Stage Melanoma
SIMPLE SUMMARY: The current standard of care for locally advanced melanoma is surgery first followed by systemic therapy. However, there is growing evidence that neoadjuvant therapy may be beneficial. The current literature supports that neoadjuvant therapy may downstage tumors and thus reduce the e...
Autores principales: | Bushara, Omar, Tidwell, Jerica, Wester, James R., Miura, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340212/ https://www.ncbi.nlm.nih.gov/pubmed/37444454 http://dx.doi.org/10.3390/cancers15133344 |
Ejemplares similares
-
The emergence of neoadjuvant therapy in advanced melanoma
por: Sun, James, et al.
Publicado: (2019) -
Neoadjuvant therapy of locally/regionally advanced melanoma
por: Khunger, Arjun, et al.
Publicado: (2019) -
Neoadjuvant relatlimab and nivolumab in resectable melanoma
por: Amaria, Rodabe N., et al.
Publicado: (2022) -
Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials
por: Witt, Russell G., et al.
Publicado: (2022) -
Neoadjuvant chemotherapy in advanced-stage ovarian cancer – state of the art
por: Margioula-Siarkou, Chrysoula, et al.
Publicado: (2022)